Kanadex-N Cream 15G Indications
Kanadex-N 15G Cream is primarily indicated in conditions like Adrenocortical insufficiency, Anorexia in palliative care, Brain tumors, Cerebral oedema, Congenital adrenal hyperplasia, Dyspnoea, Dyspnoea in palliative care, Headache due to raised intracranial pressure in palliative care, Nausea and vomiting (chemotherapy induced), Pain due to nerve compression in palliative care, Palliative surgery., Raised intracranial pressure, Respiratory distress syndrome, Shock, Suppression of inflammatory and allergic disorders, and can also be given in adjunctive therapy as an alternative drug of choice in Asthma, Blood disorders, Connective tissue diseases, GI diseases, Liver diseases, Malignancy, Ocular diseases, osteoarthiritis of superficial joints, Osteoarthritis, Renal diseases.
Kanadex-N 15G Cream is contraindicated in conditions like Diabetes mellitus, Hyp ertension, Psychosis, Osteoporosis,GI ulceration, Infections, Renal insufficiency.
The severe or irreversible adverse effects of Kanadex-N 15G Cream, which give rise to further complications include Glaucoma, Peptic ulceration, Myopathy, Osteoporosis, Posterior subcapsular cataract, Growth retardation, Aseptic bone necrosis, Ocular hypertension, Subcapsular cataract, Pancreatic disturbance, Cushing like features, Oedema, Retinal detachment, Moon face, Truncal obesity, Negative calcium balance.Kanadex-N 15G Cream produces potentially life-threatening effects which include Collapse, Suppression of hypothalamus-pituitary-adrenal axis. which are responsible for the discontinuation of Kanadex-N 15G Cream therapy. The symptomatic adverse reactions produced by Kanadex-N 15G Cream are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Insomnia, Nervousness, Nocturia, Increased appetite, Obesity, Facial rounding, Fragility of skin, Euphoria, Glucose intolerance, nervousness, Nervousness, adrenal suppression, protein catabolism, lipid metabolism.
Kanadex-N 15G Cream should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoprosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid cause growth retardation and prolonged use is rarely justified. Passive immunization is recommended to non-immune patients who do come in contact with chickenpox or measles. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3 months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examined regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy. Use nasal steroids with caution until healing has occurred. Dose adjustment required in patient with renal